NuCana plc: Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's '190 Patent is Not Valid
Ruling Has No Impact on NuCana's Anti-Cancer ProTide PatentsMUNICH, Germany, March 24, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that, following a hearing on March 24, 2023, the Technical